Incyte (INCY) free cash flow

Free cash flow · fiscal 2025
$1.33B

Incyte (INCY) generated free cash flow of $1.33B in fiscal 2025 (the year ended December 31, 2025). That is 465.4% higher than the $235.17M of fiscal 2024. Figures as of 18 Nov 2026, 12:26 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.33B
Change on fiscal 2024
+465.4%
Growth, 10 years
+35.6% a year
Highest on record
$1.33Bfiscal 2025
Lowest on record
-$311.98Mfiscal 2020
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Incyte free cash flow, in more detail

Over the ten fiscal years to 2025 free cash flow grew at a compound 35.6% a year. Across the 17 fiscal years on record (2009–2025), the highest was $1.33B in fiscal 2025 and the lowest -$311.98M in fiscal 2020.

History · 17 fiscal years

Free cash flow by fiscal year

Incyte free cash flow, year by year

Incyte (INCY) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.33B 465.4% up
2024$235.17M 47.6% down
2023$449.00M 49.7% down
2022$892.11M 56.9% up
2021$568.48M—
2020-$311.98M 149.3% down
2019$632.59M 140.8% up
2018$262.74M—
2017-$204.01M 210.6% down
2016$184.48M 191.0% up
2015$63.41M—
2014-$1.62M 133.0% down
2013$4.91M—
2012-$97.67M—
2011-$165.51M 276.4% down
2010$93.83M 683.8% up
2009$11.97M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Incyte and comparable companies
CompanyFree cash flowFiscal year
STERIS STE$972.40M2026
Insmed INSM-$967.58M2025
United Therapeutics UTHR$1.04B2025
Incyte INCY$1.33B2025
Viatris VTRS$1.85B2025
Tenet Healthcare THC$2.53B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on INCY

Incyte, figure by figure

Incyte (INCY) overview: price, valuation and scorecardAll health care companies by market value

Incyte free cash flow: questions and answers

What is Incyte's free cash flow?

Incyte (INCY) generated free cash flow of $1.33B in fiscal 2025 (the year ended December 31, 2025). That is 465.4% higher than the $235.17M of fiscal 2024.

What is the growth rate of Incyte's free cash flow?

Over the ten fiscal years to 2025 free cash flow grew at a compound 35.6% a year.

What are the highest and lowest free cash flow figures on record for Incyte?

Across the 17 fiscal years on record (2009–2025), the highest was $1.33B in fiscal 2025 and the lowest -$311.98M in fiscal 2020.

How is Incyte's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Incyte it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Incyte (INCY) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/INCY/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.